Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EBS · against 382 other Healthcare companies of similar size
Ranked #344 of 383 · scores higher than 10% of peers · safety percentile 10
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)41 peers with a safety percentile of 0–9, including EBS · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | EBS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 352 reported | 1.72× | 0.19× | 8% | 33% | |
| BetaLower is better · 367 reported | 2.37 | 0.45 | 2% | 33% | |
| Current ratioHigher is better · 377 reported | 5.42× | 2.96× | 70% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 165M USD | 99 | 50 | |
| 4 | 261M USD | 99 | 97 | |
| 5 | 397M USD | 99 | 37 | |
| 340 | 487M USD | 11 | 24 | |
| 341 | 222M USD | 10 | 31 | |
| 342 | 365M EUR (≈$401M) | 10 | 44 | |
| 343 | 522M USD | 10 | 12 | |
| 344 | 320M USD | 10 | 44 | |
| 345 | 336M USD | 9 | 43 | |
| 346 | 464M USD | 9 | 53 | |
| 347 | 513M USD | 9 | 31 | |
| 348 | 532M USD | 9 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score